Apparent species differences in the kinetic properties of P2X(7) receptors

Citation
Ad. Hibell et al., Apparent species differences in the kinetic properties of P2X(7) receptors, BR J PHARM, 130(1), 2000, pp. 167-173
Citations number
18
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BRITISH JOURNAL OF PHARMACOLOGY
ISSN journal
00071188 → ACNP
Volume
130
Issue
1
Year of publication
2000
Pages
167 - 173
Database
ISI
SICI code
0007-1188(200005)130:1<167:ASDITK>2.0.ZU;2-M
Abstract
1 Apparent species differences in the responses of recombinant P2X(7) recep tors to repeated application of 2'- and 3'-O-(4-benzoylbenzoyl)-ATP (BzATP) have been investigated. 2 Repeated application of 100 mu M BzATP resulted in a progressive increase in current magnitude (current growth) at mouse and human, but not rat P2X( 7) receptors. 3 Current growth was thought to reflect progressive dilation of the P2X(7) ion-channel to a pore permeable to large molecules (MW < 900), suggesting t hat channel dilation was not occurring at the rat P2X(7) receptor. However, 100 mu M BzATP produced a rapid influx of YO-PRO-1 (MW375) in cells expres sing rat or human P2X(7) receptors. 4 There were, however, species differences in agonist potency such that 100 mu M BzATP was a supra-maximal concentration at rat, but not human or mous e, P2X(7) receptors. Importantly, when sub-maximal concentrations of BzATP or ATP were examined, current growth occurred at rat P2X(7) receptors. 5 The rate of current growth and YO-PRO-1 accumulation increased with agoni st concentration and appeared more rapid at rat and human, than at mouse P2 X(7) receptors. 6 The potency of BzATP and ATP was 1.5-10 fold lower in naive cells than in cells repeatedly exposed to ATP. 7 This study demonstrates that current growth occurs at mouse, rat and huma n P2X(7) receptors but only when using sub-maximal concentrations of agonis t. Previously, current growth was thought to reflect the progressive increa se in pore diameter of the P2X(7) receptor ion channel, however, the result s of this study suggest a progressive increase in agonist potency may also contribute.